Editors' ChoiceCancer

On the origin of relapse in AML

See allHide authors and affiliations

Science Translational Medicine  12 Jul 2017:
Vol. 9, Issue 398, eaan8205
DOI: 10.1126/scitranslmed.aan8205


Preexisting therapy-resistant leukemia stem cell populations underlie the cellular origin of relapse in acute myeloid leukemia.

View Full Text

Stay Connected to Science Translational Medicine